Investigation of tear production dynamics in patients with age-related cataract before and after phacoemulsification

Cover Page


Cite item

Abstract

Purpose. To investigate the tear production (TP) dynamics in patients with age-related cataract before and after phacoemulsification (PE).

Material and methods. 136 patients (136 eyes) admitted for age-related cataract treatment. Age – 69.3 ± 6.4 years. 64 men and 72 women. Besides standard ophthalmological examination, in all patients Schirmer`s I test was performed before surgery on the next day, 7, 14 and 30 days after surgery. Patients were divided into 4 groups. The 1st group consisted of 32 patients (32 eyes) with TP 15 mm and more. The 2nd group – 48 patients (48 eyes) with TP from 10 to 15 mm. The 3rd group – 40 patients (40 eyes) with TP from 5 to 10 mm. The 4th group – 16 patients (16 eyes) with TP less than 5 mm. In all patients, PE was performed according to standard technology.

Results. All surgeries were performed without complications. In 56 eyes of groups 3 and 4 (41.2%) there was depression of TP of moderate and severe degree before surgery. The first day after surgery in all study groups there was twofold increase of Schirmer`s test indices. Starting from 7th day after surgery, in all groups, a 22-35% decrease of TP from baseline was observed. Later on, a gradual increase of TP was noted. On the 30th day after PE, Schirmer`s test indices were lower than those of baseline in 4 eyes (13%) of the 1st group, 10 eyes (21%) of the 2nd group, 31 eyes (77%) of the 3rd group, and 10 eyes (63%) of the 4th study group.

Conclusions. The study of TP in patients with age-related cataract showed that during one month after surgery TP returned to baseline indices only in 59.6% of patients. Regardless of its baseline indices, after the surgery, there is an universal TP dynamics, which is characterized by its initial increase, subsequent decrease and gradual return to baseline indices. Patients with initial low TP indices have potentially high risk of developing clinically significant dry eye syndrome.

Full Text

Introduction

The prevention and treatment of dry eye syndrome (DES) after eye surgery present a significant challenge for ophthalmologists. Among patients who have undergone surgery on the anterior segment of the eye, the prevalence of DES varies between 3.6% and 16% [1–6]. DES substantially reduces the quality of medical and social rehabilitation in such patients. The most frequently utilized surgical ophthalmic procedure is cataract surgery, with an estimated 20 million procedures being performed annually worldwide [7]. The major risk factors for DES after phacoemulsification (PE) include damage to the corneal and conjunctival epithelia, damage to corneal nerve fibers resulting in impaired tear production (TP) at the level of the cornea–trigeminal nerve–lacrimal gland, corneal asphericity, and the long-term application of antibacterial and anti-inflammatory eye drops after surgery [7–15]. Elderly patients with cataract often have several risk factors for reduced TP or impaired tear film stability (including concomitant somatic diseases and the systemic use of drugs), which cause combined forms of DES [16, 17]. Thus, several patients develop or experience an exacerbation of DES after PE, which reduces the functional impact of the surgery [8, 18, 19]. Therefore, for preventing DES, patients with age-related cataract (ARC) require a detailed examination of TP at all stages of treatment.

The aim of this study was to assess the dynamics of TP in patients with ARC after PE.

Materials and Methods

The present study included 136 patients (136 eyes) aged between 62 and 83 years (mean age, 69.3 ± 6.4 years) who underwent surgical treatment for ARC. The cohort comprised 64 males and 72 females. The main inclusion criteria included initial or immature ARC and sufficient mydriasis that was considered optimal for surgery.

In addition to the standard ophthalmologic examination (refractometry, ophthalmometry, biometry, ophthalmoscopy, and tonometry), all patients underwent Schirmer I test prior to surgery and then at 1, 7, 14, and 30 days post-surgery using commercially available test strips (Bausch & Lomb, USA). TP was measured according to the following standard method: the end of a test strip was bent at 45° and placed behind the lower eyelid in the lateral third of the eye fissure (without touching the cornea). After 5 min, the test strip was removed, and the length of tear absorption on the strip was measured for the assessment of TP.

After examination, all patients were divided into four groups depending on the level of TP (according to the classification developed by E.E. Somov and V.V. Brzhesky) [1]. Group 1 included 32 patients (32 eyes) with a strip wetting length of ≥ 15 mm (normal TP); group 2 included 48 patients (48 eyes) with wetting lengths between 10 and 15 mm; group 3 included 40 patients (40 eyes) with wetting lengths between 5 and 10 mm (moderate suppression of TP); and group 4 included 16 patients (16 eyes) with a wetting length of < 5 mm (severe suppression of TP).

Patients with pronounced symptoms of DES, infectious diseases of the anterior segment of the eye, or glaucoma were excluded from the analysis.

All patients underwent PE according to the standard phaco-chop technique using the Infiniti phacoemulsification system (Alcon, USA), and were implanted with various acrylic intraocular lenses (IOLs).

Post-surgically, all patients received drops of a 0.5% Signicef solution four times a day for 7 days and 0.1% dexamethasone in decreasing doses for a month, starting at four times a day.

Results and Discussion

None of the patients developed postoperative complications, and the postoperative period was uneventful.

The TPs of the patients with ARC at various time points after PE are shown in Table 1. We observed that 56 patients from groups 3 and 4 (41.2%) exhibited moderate-to-severe suppression of TP before surgery and, therefore, an increased risk of developing DES after PE.

 

Table 1. Tear production indices in patients with age-related cataract before and various time points after phacoemulsification, absolute values (M ± m)

Таблица 1. Показатели слезопродукции у пациентов с возрастной катарактой перед и в различные сроки после факоэмульсификации, абс. (M ± m)

Group,
number of eyes

Schirmer I test (mm)

Before
surgery

Time point

Day 1

Day 7

Day 14

Day 30

Group ١, ٣٢ eyes (24٪)

15–17 (15.8 ± 1.2)

25–27 (25.5 ± 1.4)

8–12 (10.4 ± 2.8)

8–14 (12.6 ± 2.9)

13–16 (14.2 ± 1.8)

Group ٢, ٤٨ eyes (٣٥٪)

10–13 (11.1 ± 1.7)

15–25 (19.7 ± 3.5)

5–10 (7.3 ± 3.1)

7–10 (8.1 ± 1.8)

9–11 (9.8 ± 1.4)

Group 3, 40 eyes (29٪)

5–7 (5.9 ± 2.1)

10–17 (12.2 ± 3.3)

3–5 (3.8 ± 1.3)

3–7 (4.1 ± 2.2)

3–5 (3.7 ± 1.7)

Group 4, 16 eyes (12٪)

2–4 (3.2 ± 0.6)

5–12 (6.6 ± 2.7)

2–4 (2.4 ± 0.7)

2–4 (2.3 ± 0.7)

2–3 (2.4 ± 0.5)

 

During the first day after surgery, all patients demonstrated an almost twofold increase of TP in the Schirmer test, and this was probably induced by a direct intraoperative corneal injury.

Starting from day 7 after surgery, we observed a 22%–35% reduction in TP in all groups, followed by a gradual increase. However, none of the patients achieved their preoperative levels of TP. The most significant suppression of TP was observed in group 4.

By day 30 after PE, 31 patients from group 3 (77%) and 10 patients from group 4 (21%) maintained decreased TP compared with baseline values. Four patients from group 1 (13%) and 10 patients from group 2 (63%) also failed to reach their baseline TP, probably because of the long-term application of anti-inflammatory eye drops containing preservative agents.

Conclusion

Our results suggest that only 60% of patients with ARC achieved their baseline TP within 1 month after PE. We observed similar dynamics of TP in all patients, regardless of their baseline TP rates; this included an initial increase in TP with subsequent reduction, followed by a gradual restoration. Fifty-six patients with initially suppressed TP (41%; groups 3 and 4) had a high risk of DES after surgery.

×

About the authors

Sergey V. Tonkonogiy

State Institution Eye Microsurgery Complex named after S.N. Fyodorov, Khabarovsk branch

Author for correspondence.
Email: naukakhvmntk@mail.ru
SPIN-code: 4799-1383

MD, cataract surgeon

Russian Federation, Khabarovsk

Lina U. Bai

State Institution Eye Microsurgery Complex named after S.N. Fyodorov, Khabarovsk branch

Email: naukakhvmntk@mail.ru
SPIN-code: 2005-4948

MD, cataract surgeon

Russian Federation, Khabarovsk

Aleksey V. Vasilyev

State Institution Eye Microsurgery Complex named after S.N. Fyodorov, Khabarovsk branch

Email: naukakhvmntk@mail.ru
SPIN-code: 5780-0798

MD, PhD, DMedSc, Head of Department

Russian Federation, Khabarovsk

References

  1. Бржеский В.В., Сомов Е.Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение). – СПб., 2003. [Brzheskiy VV, Somov EE. Corneal conjunctival xerosis (diagnostics, clinic, treatment). Saint Petersburg; 2003. (In Russ.)]
  2. Foster A. Vision 2020: the cataract challenge. Community eye health. 2000;13(34):17-19.
  3. Garcia-Catalan MR, Jerez-Olivera E, Benitez-Del-Castillo-Sanchez JM. Dry eye and quality of life. Arch Soc Esp Oftalmol. 2009;84(9):451-458.
  4. Na KS, Han K, Park YG, et al. Depression, Stress, Quality of Life, and Dry Eye Disease in Korean Women: A Population-Based Study. Cornea. 2015;34(7):733-738. doi: 10.1097/ICO.0000000000000464.
  5. Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PloS One. 2013;8(11): e78657. doi: 10.1371/journal.pone.0078657.
  6. Jiang D, Xiao X, Fu T, et al. Transient Tear Film Dysfunction after Cataract Surgery in Diabetic Patients. PloS One. 2016;11(1): e0146752. doi: 10.1371/journal.pone.0146752.
  7. Al-Aqaba MA, Fares U, Suleman H, et al. Architecture and distribution of human corneal nerves. British J Ophthalmol. 2010;94(6):784-789. doi: 10.1136/bjo.2009.173799.
  8. Сомов Е.Е. Синдромы слёзной дисфункции. – СПб.: Человек, 2011. [Somov EE. Syndromes of lacrimal dysfunction. Saint Petersburg: Chelovek; 2011. (In Russ.)]
  9. Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol. 2009;23(2):65-73. doi: 10.3341/kjo.2009.23.2.65.
  10. De Paiva CS, Chen Z, Koch DD, et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006;141(3):438-445. doi: 10.1016/j.ajo.2005.10.006.
  11. Tasindi E. Синдром «сухого глаза» в послеоперационном периоде // Новое в офтальмологии. – 2012. – № 3. – C. 44–46. [Tasindi E. Dry eye syndrome in the postoperative period. Novoe v oftal’mologii. 2012;(3):44-46. (In Russ.)]
  12. Linna TU, Vesaluoma MH, Perez-Santonja JJ, et al. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Invest Ophthalmol Vis Sci. 2000;41(2):393-397.
  13. Sahu PK, Das GK, Malik A, Biakthangi L. Dry Eye Following Phacoemulsification Surgery and its Relation to Associated Intraoperative Risk Factors. Middle East Afr J Ophthalmol. 2015;22(4):472-477. doi: 10.4103/0974-9233.151871.
  14. Yu Y, Hua H, Wu M, et al. Evaluation of dry eye after femtosecond laser-assisted cataract surgery. J Cataract Refract Surg. 2015;41(12):2614-2623. doi: 10.1016/j.jcrs.2015.06.036.
  15. Cetinkaya S, Mestan E, Acir NO, et al. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol. 2015;15:68. doi: 10.1186/s12886-015-0058-3.
  16. Ерёменко А.И., Бойко А.А., Янченко С.В., и др. Профилактика комбинированного синдрома сухого глаза у пациентов старшей возрастной группы после катарактальной хирургии // РМЖ. Клиническая офтальмология. – 2006. – № 3. – С. 122–125. [Eremenko AI, Boyko AA, Yanchenko SV, et al. Prophylaxis of secondary dry eye syndrome after the cataract extraction with IOL implantation. RMZh. Klinicheskaya oftal’mologiya. 2006;(3):122-125. (In Russ.)]
  17. Полунин Г.С., Куренков В.В., Сафонова Т.Н., Полунина Е.Г. Новая клиническая классификация синдрома «сухого глаза» // Катарактальная и рефракционная хирургия. – 2003. – Т. 3. – № 3. – С. 53–56. [Polunin GS, Kurenkov VV, Safonova TN, Polunina EG. New clinical classification of dry eye syndrome. Kataraktal’naya i refraktsionnaya khirurgiya. 2003;3(3):53-56. (In Russ.)]
  18. Майчук Ю.Ф., Яни Е.В. Клиническая оценка препаратов гиалуроновой кислоты. Визмед® глазные капли и Визмед-гель® в монодозах в лечении синдрома сухого глаза // Катарактальная и рефракционная хирургия. – 2008. – Т. 8. – № 4. – С. 35–42. [Maychuk YF, Yani EV. Clinical efficacy of hyaluronic acid preparations: Vismed® (eye drops) and Vismed Gel® (eye gel) in monodoses at the treatment of dry eye. Kataraktal’naya i refraktsionnaya khirurgiya. 2008;8(4):35-42. (In Russ.)]
  19. Трубилин В.Н., Седнева Т.А., Капкова С.Г. Слезозаместительная терапия в профилактике и лечении синдрома «сухого глаза» после катарактальной хирургии // Офтальмология. – 2013. – Т. 10. – № 1. – С. 56–62. [Trubilin VN, Sedneva TA, Kapkova SG. The tear substitutive therapy for prophylaxis and treatment of dry eye after cataract surgery. Ophthalmology. 2013;10(1):56-62. (In Russ.)]

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Tonkonogiy S.V., Bai L.U., Vasilyev A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies